The novel integrin-linked kinase inhibitor nilotinib suppresses cancer progression by promoting ubiquitylation of autoimmune regulator in oesophageal squamous cell carcinoma
Ma Xiaoli, Wei Yu, Cao LeiYu, Gao Yan, Qu Chengcheng, Muhetaer Kalima, Zhang Li
Journal:ANTI-CANCER DRUGS
IF:2
DOI:10.1097/CAD.0000000000001828
PMID:
Published:2026-04-28
research field:免疫疗法生物医学工程纳米技术癌症治疗
Abstract
本文使用的Yeasen产品
相关产品
推荐应用


